MedTrace Logo

LLLT Combined With CDT in Breast Cancer-Related Lymphedema

NCT01351376 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2019-09-19

Study results available
· View outcomes & findings →

Summary

This study aims to explore the effects of Low Level Laser Therapy (LLLT) on breast cancer-related lymphedema when utilized in conjunction with Complex Decongestive Therapy (CDT) when compared to CDT treatment alone. The investigators hypothesize that the addition of LLLT to CDT will result in statistically significant improvements and greater long-term benefits as measured by changes in arm volume and quality of life when compared to the benefits of CDT alone for the treatment of breast cancer-related lymphedema.

Conditions

Interventions

DEVICE

Low Level Laser Therapy

Placebo LLL combined with CDT

DEVICE

Low Level Laser

Active LLL combined with CDT

Sponsors & Collaborators

Principal Investigators

  • Teresa Denham, PT, MA · NYU Rusk Institute of Rehabilitation Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2016-06-30
Completion
2017-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01351376 on ClinicalTrials.gov